Cargando…

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response

INTRODUCTION: Colon cancer is the 3(rd) most prevalent cancer worldwide, with more than 900,000 deaths annually. Chemotherapy, targeted treatment, and immunotherapeutic treatment are the three cornerstones of colon cancer treatment; however, the occurrence of immune therapy resistance is the most pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bomiao, Li, Yien, Song, Liqiang, Xi, Hua, Wang, Shaoke, Yu, Chenfeng, Cui, Binbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060792/ https://www.ncbi.nlm.nih.gov/pubmed/37007132 http://dx.doi.org/10.3389/fonc.2023.1061084

Ejemplares similares

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Integrative pan-cancer analysis of cuproplasia-associated genes for the genomic and clinical characterization of 33 tumors
por: Li, Xinyu, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer
por: Xia, Tianyi, et al.
Publicado: (2022)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma
por: Wang, Jinyan, et al.
Publicado: (2023)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

Experiences and Expectations for Glioma Immunotherapeutic Approaches
por: Yamanaka, Ryuya, et al.
Publicado: (2014)

Immunotherapeutic Potential of T Memory Stem Cells
por: Li, Yujie, et al.
Publicado: (2021)

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC
por: He, Ping, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment
por: Kaimala, Suneesh, et al.
Publicado: (2018)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
por: Meyers, Daniel E., et al.
Publicado: (2017)

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
por: Xie, Yalin, et al.
Publicado: (2022)

Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
por: Piper, Keenan, et al.
Publicado: (2021)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
por: Song, Binyu, et al.
Publicado: (2022)

A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients
por: Chang, Kaili, et al.
Publicado: (2021)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination
por: Wang, Yi, et al.
Publicado: (2022)

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
por: Ortiz, Michael V., et al.
Publicado: (2019)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
por: Hirani, Priyanka, et al.
Publicado: (2021)

Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma
por: Chi, Xiaohan, et al.
Publicado: (2022)

A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
por: Nie, Jianhua, et al.
Publicado: (2021)

Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer
por: Wu, Mingjian, et al.
Publicado: (2023)

Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction
por: Jones, Meredith A., et al.
Publicado: (2022)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma
por: Zhou, Jiahui, et al.
Publicado: (2023)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
por: Li, Zhufeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_otkflvcajqc4if86udrhkjbcao